AN OPEN LABEL STUDY TO DETERMINE THE SAFETY AND TOLERABILITY OF 12 WEEKS TREATMENT WITH ORAL REN001 IN SUBJECTS WITH FATTY ACID OXIDATION DISORDERS (FAOD)

Project: Research project

Project Details

StatusActive
Effective start/end date4/9/198/31/50

Funding

  • Reneo Pharma Ltd.